Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 17, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 2,502 | $264.62 | $662,079.24 |
DisclosureSEC source: 0001193125-26-393422 · ownership.xml · nonDerivative · entry 3 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,794 F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $264.45 to $265.02. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 4,025 | $264.10 | $1,063,002.50 |
DisclosureSEC source: 0001193125-26-393422 · ownership.xml · nonDerivative · entry 2 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,296 F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $263.45 to $264.44. Read SEC document |
| September 14, 2026 Filed Sep 17, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 5,483 | $263.04 | $1,442,248.32 |
DisclosureSEC source: 0001193125-26-393422 · ownership.xml · nonDerivative · entry 1 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,321 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $262.43 to $263.37. Read SEC document |
| September 10, 2026 Filed Sep 15, 2026 00:00 UTC |
MARK RICHARD JDirector
|
SaleCommon Stock | 10,000 | $263.42 | $2,634,200.00 |
DisclosureSEC source: 0001193125-26-391004 · ownership.xml · nonDerivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,121 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $263.15 to $264.03. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 00:00 UTC |
West NadjaDirector
|
SaleCommon Stock | 1,152 | $258.80 | $298,137.60 |
DisclosureSEC source: 0001193125-26-382368 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,653 Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 00:00 UTC |
Foo Lisa YEVP, Chief Operating Officer
|
SaleCommon Stock | 24,000 | $266.32 | $6,391,680.00 |
DisclosureSEC source: 0001193125-26-379021 · ownership.xml · nonDerivative · entry 1 Foo Lisa Y · CIK 0001916153 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,053 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $266.02 to $266.95. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 00:00 UTC |
HANEY CECIL DDirector
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-377240 · ownership.xml · nonDerivative · entry 1 HANEY CECIL D · CIK 0001769664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,403 F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 00:00 UTC |
Sutaria SaumyaDirector · CEO
|
SaleCommon Stock | 7,899 | $275.26 | $2,174,278.74 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 5 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,564 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 00:00 UTC |
Sutaria SaumyaDirector · CEO
|
SaleCommon Stock | 24,881 | $274.10 | $6,819,882.10 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 4 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,463 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F5 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 00:00 UTC |
Sutaria SaumyaDirector · CEO
|
SaleCommon Stock | 17,220 | $273.34 | $4,706,914.80 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 3 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 466,344 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64. Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 00:00 UTC |
HANEY CECIL DDirector
|
SaleCommon Stock | 1,300 | $278.03 | $361,439.00 |
DisclosureSEC source: 0001193125-26-369163 · ownership.xml · nonDerivative · entry 1 HANEY CECIL D · CIK 0001769664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,553 Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 00:00 UTC |
Sutaria SaumyaDirector · CEO
|
SaleCommon Stock | 36,656 | $278.90 | $10,223,358.40 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 2 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,564 F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14. Read SEC document |
| August 24, 2026 Filed Aug 27, 2026 00:00 UTC |
Sutaria SaumyaDirector · CEO
|
SaleCommon Stock | 13,344 | $278.17 | $3,711,900.48 |
DisclosureSEC source: 0001193125-26-369162 · ownership.xml · nonDerivative · entry 1 Sutaria Saumya · CIK 0001760857 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 520,220 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57. F2 · price: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 00:00 UTC |
Romo TammyDirector
|
SaleCommon Stock | 2,500 | $260.83 | $652,075.00 |
DisclosureSEC source: 0001193125-26-342970 · ownership.xml · nonDerivative · entry 2 Romo Tammy · CIK 0001558014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,284 Read SEC document |
| August 06, 2026 Filed Aug 11, 2026 00:00 UTC |
Romo TammyDirector
|
SaleCommon Stock | 4,922 | $264.15 | $1,300,146.30 |
DisclosureSEC source: 0001193125-26-342970 · ownership.xml · nonDerivative · entry 1 Romo Tammy · CIK 0001558014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,784 Read SEC document |
| August 05, 2026 Filed Aug 8, 2026 00:00 UTC |
Blunt RoyDirector
|
SaleCommon Stock | 600 | $262.68 | $157,608.00 |
DisclosureSEC source: 0001193125-26-340735 · ownership.xml · nonDerivative · entry 1 Blunt Roy · CIK 0001986272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,589 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $262.52 to $262.70. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 29, 2026 Filed Aug 1, 2026 00:00 UTC |
Foo Lisa YEVP, Chief Operating Officer
|
SaleCommon Stock | 10,000 | $258.03 | $2,580,300.00 |
DisclosureSEC source: 0001193125-26-329146 · ownership.xml · nonDerivative · entry 1 Foo Lisa Y · CIK 0001916153 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,053 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $257.97 to $258.43. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 00:00 UTC |
Lynch Christopher S.Director
|
SaleCommon Stock | 3,837 | $243.44 | $934,079.28 |
DisclosureSEC source: 0001193125-26-321682 · ownership.xml · nonDerivative · entry 1 Lynch Christopher S. · CIK 0001452627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,568 Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 00:00 UTC |
Arbour Paola MEVP, Chief Information Officer
|
SaleCommon Stock | 10,878 | $243.90 | $2,653,144.20 |
DisclosureSEC source: 0001193125-26-321681 · ownership.xml · nonDerivative · entry 1 Arbour Paola M · CIK 0001769862 · EVP, Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,413 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $243.82 to $244.08. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 27, 2026 Filed Jul 29, 2026 00:00 UTC |
BIERMAN JAMES LDirector
|
SaleCommon Stock | 5,000 | $244.96 | $1,224,800.00 |
DisclosureSEC source: 0001193125-26-321680 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,604 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $244.95 to $245.29. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 361 | $177.52 | $64,084.72 |
DisclosureSEC source: 0001193125-26-249167 · ownership.xml · nonDerivative · entry 5 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,804 F5 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $177.25 to $178.08. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 905 | $176.89 | $160,085.45 |
DisclosureSEC source: 0001193125-26-249167 · ownership.xml · nonDerivative · entry 4 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,165 F4 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $176.21 to $177.20. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 713 | $175.13 | $124,867.69 |
DisclosureSEC source: 0001193125-26-249167 · ownership.xml · nonDerivative · entry 3 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,070 F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $174.92 to $175.69. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 1,690 | $173.97 | $294,009.30 |
DisclosureSEC source: 0001193125-26-249167 · ownership.xml · nonDerivative · entry 2 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,783 F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $173.69 to $174.37. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
SaleCommon Stock | 1,969 | $173.12 | $340,873.28 |
DisclosureSEC source: 0001193125-26-249167 · ownership.xml · nonDerivative · entry 1 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,473 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $172.63 to $173.60. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
Agarwala VineetaDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245814 · ownership.xml · derivative · entry 1 Agarwala Vineeta · CIK 0002003663 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
Blunt RoyDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245813 · ownership.xml · derivative · entry 1 Blunt Roy · CIK 0001986272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
MARK RICHARD JDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245812 · ownership.xml · derivative · entry 1 MARK RICHARD J · CIK 0001190100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
West NadjaDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245811 · ownership.xml · derivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
West NadjaDirector
|
SaleCommon Stock | 3,000 | $177.35 | $532,050.00 |
DisclosureSEC source: 0001193125-26-245811 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,805 Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
FISHER RICHARD WDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245810 · ownership.xml · derivative · entry 1 FISHER RICHARD W · CIK 0001287510 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
HANEY CECIL DDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245809 · ownership.xml · derivative · entry 1 HANEY CECIL D · CIK 0001769664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
BIERMAN JAMES LDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245808 · ownership.xml · derivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
Romo TammyDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245807 · ownership.xml · derivative · entry 1 Romo Tammy · CIK 0001558014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
Lynch Christopher S.Director
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245806 · ownership.xml · derivative · entry 1 Lynch Christopher S. · CIK 0001452627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
KERREY J ROBERTDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245805 · ownership.xml · derivative · entry 1 KERREY J ROBERT · CIK 0001179100 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,464 Underlying: Common Stock · 1,464 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 27, 2026 Filed May 29, 2026 00:00 UTC |
Fitzgerald MeghanDirector
|
Grant2026 May Restricted Stock Units · Derivative | 1,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-245804 · ownership.xml · derivative · entry 1 Fitzgerald Meghan · CIK 0001349297 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188 Underlying: Common Stock · 1,188 shares Expires 2027-05-27 F1 · derivative.exercise_price: Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
BIERMAN JAMES LDirector
|
Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239943 · ownership.xml · derivative · entry 2 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
BIERMAN JAMES LDirector
|
Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239943 · ownership.xml · nonDerivative · entry 1 BIERMAN JAMES L · CIK 0001189534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
Lynch Christopher S.Director
|
Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239942 · ownership.xml · derivative · entry 2 Lynch Christopher S. · CIK 0001452627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
Lynch Christopher S.Director
|
Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239942 · ownership.xml · nonDerivative · entry 1 Lynch Christopher S. · CIK 0001452627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. F2 · balance_after: Total reflects a decrease of 278 shares from previously filed Forms 4 to correct an error. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
West NadjaDirector
|
Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239941 · ownership.xml · derivative · entry 3 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
West NadjaDirector
|
Disposition to issuerCommon Stock | 493 | $173.78 | $85,673.54 |
DisclosureSEC source: 0001193125-26-239941 · ownership.xml · nonDerivative · entry 2 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,805 Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
West NadjaDirector
|
Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239941 · ownership.xml · nonDerivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
Romo TammyDirector
|
Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239940 · ownership.xml · derivative · entry 3 Romo Tammy · CIK 0001558014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
Romo TammyDirector
|
Disposition to issuerCommon Stock | 493 | $173.78 | $85,673.54 |
DisclosureSEC source: 0001193125-26-239940 · ownership.xml · nonDerivative · entry 2 Romo Tammy · CIK 0001558014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,706 Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
Romo TammyDirector
|
Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239940 · ownership.xml · nonDerivative · entry 1 Romo Tammy · CIK 0001558014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
FISHER RICHARD WDirector
|
Exercise / conversion2025 May Restricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239939 · ownership.xml · derivative · entry 3 FISHER RICHARD W · CIK 0001287510 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires 2026-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
FISHER RICHARD WDirector
|
Disposition to issuerCommon Stock | 493 | $173.78 | $85,673.54 |
DisclosureSEC source: 0001193125-26-239939 · ownership.xml · nonDerivative · entry 2 FISHER RICHARD W · CIK 0001287510 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,632 Read SEC document |
| May 22, 2026 Filed May 27, 2026 00:00 UTC |
FISHER RICHARD WDirector
|
Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-239939 · ownership.xml · nonDerivative · entry 1 FISHER RICHARD W · CIK 0001287510 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock. The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.